RxDoctor Payments Data

Linda Jackson

Nurse Practitioner · Pueblo, CONPI 1902906548

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,657in general payments, 2019–2025

Across 256 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$717
  • Novo Nordisk$556
  • AbbVie$426
  • Amgen$403
  • Pfizer$379
  • Bayer$241
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,657100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,657 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$99,872
OzempicSemaglutide45$53,804
XareltoRivaroxaban49$44,741
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$33,962
Tresiba Flextouch U-200Insulin Degludec28$25,946
TrulicityDulaglutide24$22,854
JardianceEmpagliflozin22$20,258
JanuviaSitagliptin Phosphate33$17,644
Tresiba Flextouch U-100Insulin Degludec19$14,320
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$14,017
Repatha SureclickEvolocumab21$11,863
MyrbetriqMirabegron18$10,277
Victoza 2-PakLiraglutide13$7,813
Spiriva RespimatTiotropium Bromide12$6,335
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$5,677

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$379$99,872127 claims
Novo NordiskOzempic$556$53,80445 claims
GSKTrelegy Ellipta, Anoro Ellipta$63$47,97955 claims
Johnson & JohnsonXarelto$143$44,74149 claims
Boehringer IngelheimJardiance, Spiriva Respimat$95$26,59234 claims
Lilly USA, LLCTrulicity, Humalog$241$24,67835 claims
MerckJanuvia, Dulera$15$21,71545 claims
Astellas Pharma US IncMyrbetriq$162$10,27718 claims
AbbVieSynthroid$426$3,04756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →